The epithelial–mesenchymal transition (EMT) is a cellular transdifferentiation program that enables epithelial cancer cells to acquire traits of high-grade malignancy, notably invasive and metastatic powers. A new study indicates that it may also function early in tumour progression by preventing oncogene-induced senescence.
References
Hay, E. D. Dev. Dyn. 233, 706–720 (2005).
Thiery, J. P. Nature Rev. Cancer 2, 442–454 (2002).
Ansieau, S. et al. Cancer Cell 14, 79–89 (2008).
Fidler, I. J. Nature Rev. Cancer 3, 453–458 (2003).
Mani, S. A. et al. Cell 133, 704–715 (2008).
Fischer, A. N. et al. Oncogene 26, 3395–3405 (2007).
Vega, S. et al. Genes Dev. 18, 1131–1143 (2004).
Cheng, G. Z. et al. Cancer Res. 67, 1979–1987 (2007).
Land, H., Parada, L. F. & Weinberg, R. A. Nature 304, 596–602 (1983).
Ruley, H. E. Nature 304, 602–606 (1983).
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Cell 88, 593–602 (1997).
Tuveson, D. A. et al. Cancer Cell 5, 375–387 (2004).
Prieur, A. & Peeper, D. S. Curr. Opin. Cell Biol. 20, 150–155 (2008).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weinberg, R. Twisted epithelial–mesenchymal transition blocks senescence. Nat Cell Biol 10, 1021–1023 (2008). https://doi.org/10.1038/ncb0908-1021
Issue Date:
DOI: https://doi.org/10.1038/ncb0908-1021
- Springer Nature Limited
This article is cited by
-
RNF43 ubiquitinates and degrades phosphorylated E-cadherin by c-Src to facilitate epithelial-mesenchymal transition in lung adenocarcinoma
BMC Cancer (2019)
-
Gene regulatory network underlying the immortalization of epithelial cells
BMC Systems Biology (2017)
-
Antibody–Drug Conjugates for the Treatment of Solid Tumors: Clinical Experience and Latest Developments
Targeted Oncology (2017)
-
Optimisation of an immunohistochemistry method for the determination of androgen receptor expression levels in circulating tumour cells
BMC Cancer (2014)
-
Notch3 is important for TGF-β-induced epithelial–mesenchymal transition in non-small cell lung cancer bone metastasis by regulating ZEB-1
Cancer Gene Therapy (2014)